leadf
logo-loader
viewBlack Bear Energy Resources Plc

Black Bear Energy Resources - - Elevator Pitch

"Black Bear Energy Resources is committed to solid returns and exceptional value for all shareholders." Tony Mason, CEO

"Black Bear Energy Resources is committed to solid returns and exceptional value for all shareholders." Tony Mason, CEO

Society is demanding more energy solutions, delivered in new and better ways, for a low carbon future. At Black Bear Energy Resources, we know the future starts today. Our strategy is purpose-driven to meet this challenge by responsibly extracting oil and natural gas to meet current domestic energy needs.

Through state-of-the-art 5G technologies, energy can be produced more efficiently to meet this demand. Our strategy at Black Bear Energy Resources allows us to be responsible and competitive when prices, policy, technology, and customer preferences are rapidly evolving.

The Black Bear Energy Resources focus is near-term, short-cycle oil and natural gas development projects. Our experience, expertise, and balanced portfolio embrace the energy transition with a solid basis for investors whilst continuing to responsibly meet energy needs.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

Destiny Pharma (LON:DEST) Elevator Pitch

Destiny Pharma is a clinical phase biotechnology company dedicated to the development of novel anti-infectives with a focus on infection prevention. The Company is developing novel antimicrobial drugs from its “in-house” XF platform and also from recently acquired Biotherapeutic products that...

on 03/11/2021